Importantly, it was shown recently that LRRK2 kinase activity was enhanced in post-mortem brain tissue from patients with idiopathic PD (iPD), suggesting that independent of mutations, wild-type LRRK2 plays a role in PD pathology as well (Di Maio et al., 2018). This evidence concerns the gene LRRK2 and Parkinson disease.